RAD51D Gene Mutation: Clinical Trials

1 trial for RAD51D Gene Mutation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow RAD51D Gene Mutation: new trials by email Literature Review of RAD51D Gene Mutation trials Research Report on RAD51D Gene Mutation

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Low Dose TamOxifen and LifestylE Changes for bReast cANcer prevenTion
Tamoxifen 10 mg Tablet, Intermittent caloric restriction, Step counter Device - BRCA Mutation, PALB2 Gene Mutation
Phase 2CompletedEuropean Institute of Oncology1102024-06-212026-09-11

Narrower conditions

Breast Carcinoma In Situ (1)  ·  Carcinoma, Intraductal, Noninfiltrating (1)

Broader conditions

Adenocarcinoma (1)  ·  Breast Diseases (1)  ·  Breast Neoplasms (1)  ·  Carcinoma (1)  ·  Carcinoma in Situ (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms by Site (1)  ·  Neoplasms, Ductal, Lobular, and Medullary (1)  ·  Neoplasms, Glandular and Epithelial (1)  ·  Skin Diseases (1)  ·  Skin and Connective Tissue Diseases (1)

Interventions

Tablets (1)  ·  Tamoxifen (1)

Sponsors

European Institute of Oncology (1)

Countries

Italy (1)

Top investigators

Bernardo Bonanni, MD (1)

Results publications

PMID 39226292

NIH funding

2023 (1)